FDA Inspection 1242347 — Jubilant HollisterStier General Partnership
The FDA completed an inspection of Jubilant HollisterStier General Partnership on Jun 14, 2024 in Kirkland. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 14, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kirkland (Canada)